每周股票复盘：神州细胞（688520）获近亿政府补助

Core Viewpoint - Shenzhou Cell (688520) has experienced a slight decline in stock price, closing at 44.22 yuan, down 0.79% from the previous week, with a total market capitalization of 19.693 billion yuan [1] Company Announcements Summary - Shenzhou Cell's subsidiary received two government subsidies totaling 45.27 million yuan and 50 million yuan, classified as revenue-related government grants, with the accounting treatment and impact on profits to be confirmed in the annual audit [1][3] - The subsidiary has received approval from the National Medical Products Administration for a supplemental application for its product, recombinant human coagulation factor VIII (brand name: Anjain), to be used for perioperative bleeding management in patients with hemophilia A, marking it as the first domestically approved product for this indication, which is expected to positively impact future revenue [1][3]